STRATA Skin Sciences Reports First Quarter 2023 Revenue
Achieved revenue of $7.6 million for the first quarter 2023 Company to host conference call and webcast today, May 15, 2023 , at 4:30 PM ET HORSHAM, Pa. , May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,
STRATA Skin Sciences Enters India Market with Exclusive Distribution Agreement with Spectra Medical
STRATA expects to receive regulatory approval in India during December 2023 India has the highest prevalence of vitiligo in the world, at about 8.8% 1 HORSHAM, Pa. , May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,
STRATA Skin Sciences to Participate in Inaugural EF Hutton Global Conference
HORSHAM, Pa. , May 08, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will participate in the
STRATA Skin Sciences to Report First Quarter 2023 Financial Results on May 15, 2023
HORSHAM, Pa. , May 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its first quarter
STRATA Skin Sciences Pre-Announces First Quarter 2023 Results
Preliminary revenue to be within the range of $7.3 - $7.8 million and expected to be the strongest first-quarter results since first quarter of 2016 Company exceeds plan with 44 TheraClear ® X placements in the first quarter HORSHAM, Pa. , April 12, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences,
STRATA Skin Sciences Reports Record Fourth Quarter 2022 Revenue
Achieved record revenue of $36.2 million , representing 21% increase over the year 2021 Company to host conference call and webcast today, March 31, 2023 , at 8:30 AM ET HORSHAM, Pa. , March 31, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company
STRATA Skin Sciences Reschedules Fourth Quarter 2022 Conference Call and Webcast to Friday, March 31, 2023
HORSHAM, Pa. , March 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it will release its fourth quarter 2022
STRATA Skin Sciences to Report Fourth Quarter 2022 Financial Results on March 28, 2023
HORSHAM, Pa. , March 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth
STRATA Skin Sciences Affirms No Exposure to Silicon Valley Bank
HORSHAM, Pa. , March 13, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it does not have exposure to Silicon
STRATA Skin Sciences Announces the Launch of New, Patient-Focused XTRAC® Website
Website delivers enhanced patient resources including an easy 3-step process to search, find, and communicate directly with XTRAC partner practices HORSHAM, Pa. , March 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,